Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Provider Response to QTc Prolongation on Standard 12-Lead EKG: Do We Notice or Do We Care?

Good MM, Riad FS, Good CB, Shalaby AA.

Pacing Clin Electrophysiol. 2016 Nov;39(11):1174-1180. doi: 10.1111/pace.12951. Epub 2016 Oct 10.

PMID:
27628760
2.

A computational model predicts adjunctive pharmacotherapy for cardiac safety via selective inhibition of the late cardiac Na current.

Yang PC, El-Bizri N, Romero L, Giles WR, Rajamani S, Belardinelli L, Clancy CE.

J Mol Cell Cardiol. 2016 Oct;99:151-161. doi: 10.1016/j.yjmcc.2016.08.011. Epub 2016 Aug 18.

3.

PP2 prevents isoproterenol stimulation of cardiac pacemaker activity.

Huang J, Lin YC, Hileman S, Martin KH, Hull R, Yu HG.

J Cardiovasc Pharmacol. 2015 Feb;65(2):193-202. doi: 10.1097/FJC.0000000000000078. Erratum in: J Cardiovasc Pharmacol. 2015 Apr;65(4):398. J Cardiovasc Pharmacol. 2015 Feb;65(2):192.

PMID:
25658311
4.

Changes in QTc interval in the citalopram for agitation in Alzheimer's disease (CitAD) randomized trial.

Drye LT, Spragg D, Devanand DP, Frangakis C, Marano C, Meinert CL, Mintzer JE, Munro CA, Pelton G, Pollock BG, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG; CitAD Research Group.

PLoS One. 2014 Jun 10;9(6):e98426. doi: 10.1371/journal.pone.0098426. eCollection 2014.

5.

PP2 prevents β-adrenergic stimulation of cardiac pacemaker activity.

Huang J, Lin YC, Hileman S, Martin KH, Hull R, Yu HG.

J Cardiovasc Pharmacol. 2014 Jun;63(6):533-43. doi: 10.1097/FJC.0000000000000078.

6.

Gene-environment interaction between SCN5A-1103Y and hypokalemia influences QT interval prolongation in African Americans: the Jackson Heart Study.

Akylbekova EL, Payne JP, Newton-Cheh C, May WL, Fox ER, Wilson JG, Sarpong DF, Taylor HA, Maher JF.

Am Heart J. 2014 Jan;167(1):116-122.e1. doi: 10.1016/j.ahj.2013.10.009. Epub 2013 Oct 22.

7.

Electromechanical effects of 1,25-dihydroxyvitamin d with antiatrial fibrillation activities.

Hanafy DA, Chang SL, Lu YY, Chen YC, Kao YH, Huang JH, Chen SA, Chen YJ.

J Cardiovasc Electrophysiol. 2014 Mar;25(3):317-23. doi: 10.1111/jce.12309. Epub 2013 Nov 14.

PMID:
24152033
8.

A 26-year-old woman with recurrent loss of consciousness.

Benson MR, Kotagal V, Oral H.

J Gen Intern Med. 2011 Dec;26(12):1507-12. doi: 10.1007/s11606-011-1784-8. Epub 2011 Jul 8.

9.

Assessment of repolarization heterogeneity for prediction of mortality in cardiovascular disease: peak to the end of the T wave interval and nondipolar repolarization components.

Smetana P, Schmidt A, Zabel M, Hnatkova K, Franz M, Huber K, Malik M.

J Electrocardiol. 2011 May-Jun;44(3):301-8. doi: 10.1016/j.jelectrocard.2011.03.004.

PMID:
21511064
10.

Prolongation of cardiac repolarization by arsenic trioxide.

Chiang CE, Luk HN, Wang TM, Ding PY.

Blood. 2002 Sep 15;100(6):2249-52.

11.

Effects of sildenafil on cardiac repolarization.

Chiang CE, Luk HN, Wang TM, Ding PY.

Cardiovasc Res. 2002 Aug 1;55(2):290-9.

PMID:
12123768
12.

Effect of risperidone on QT interval and QT dispersion in the elderly.

Yerrabolu M, Prabhudesai S, Tawam M, Winter L, Kamalesh M.

Heart Dis. 2000 Jan-Feb;2(1):10-2.

PMID:
11728238
13.
14.

Acquired long QT syndrome in a child undergoing craniotomy: a case report.

Hsieh YC, Chow LH, Wong TD, Jeng KN, Lui PW, Lee TY.

Zhonghua Yi Xue Za Zhi (Taipei). 1995 Sep;56(3):215-9.

PMID:
8854446
15.

Age, altitude, and arrhythmia.

Alexander JK.

Tex Heart Inst J. 1995;22(4):308-16. Review.

16.

Effects of amiodarone, sematilide, and sotalol on QT dispersion.

Cui G, Sen L, Sager P, Uppal P, Singh BN.

Am J Cardiol. 1994 Nov 1;74(9):896-900.

PMID:
7526675

Supplemental Content

Loading ...
Support Center